BrumBrum, a company focused on providing day treatment to children with developmental delays, has successfully raised $77.0M. The significant capital infusion underscores the market's confidence in its specialized approach to pediatric care.
The company's methodology is rooted in creating an environment of safety and trust, believing that only within such a framework can a child truly develop in a way that suits their individual needs. This funding will enable BrumBrum to continue its vital work in supporting these children.
